Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

New treatments offer hope for better managing hidradenitis suppurativa.

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

A young boy with Netherton syndrome improved significantly using IVIG, dupilumab, and dietary changes.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Stem-cell therapy shows promise for skin conditions but needs more research.

People with alopecia areata often have lower vitamin D levels than healthy people.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.